Delivery Order SPE2DB20D2014-SPE2DB25FC77B
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ketorolac 30 mg/mL vials valued at $2,795.75. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. The contract is issued as...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials valued at $7,762.71 on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials valued at $1,163.76 on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive delivery order placed under the company's existing indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,605.10 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-competitive, non-set-aside procurement of this pharmaceutical product. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $7,301.66 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with an ultimate completion date of August 13, 2025. This competitive award represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 60 mg/2 mL vials, with a ceiling value of $1,750.87. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 4, 2025, and represents a small-value pharmaceutical procurement typical of federal medical supply operations. The delivery will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Ketorolac 30 mg/ml vials. The contract, issued on August 8, 2025, carries a ceiling value of $1,279.84 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Ketorolac 10 mg tablets (100-count units) valued at $1,182.51. This firm fixed-price delivery order, issued on July 31, 2025, represents a non-set-aside award under open competition and is scheduled for completion by August 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC77BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 60 mg/2 ml vials with a ceiling value of $2,228.38. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying military and veteran healthcare systems with brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive portfolio of federal contracts with the DLA demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains. Through the SPE2DX global pharmaceutical support vehicle, AmerisourceBergen provides comprehensive pharmaceutical support to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a prime vendor for the Defense Logistics Agency's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/18/25 |